All Stories

From ADCs to radiopharma: How AstraZeneca is trying to ‘redefine oncology care’

AstraZeneca has been busy in recent years picking up a shopping list of assets and companies that have pumped up its oncology pipeline.

Apr 9, 2025 - 16:47
 0
From ADCs to radiopharma: How AstraZeneca is trying to ‘redefine oncology care’
AstraZeneca has been busy in recent years picking up a shopping list of assets and companies that have pumped up its oncology pipeline.
Read More

Tags:

Previous Article

PacBio to cut headcount, costs amid headwinds from trans-Pacific tariffs

Next Article

List of industry subject matter experts and list of planned calls for industry s...

Related Posts

Cullinan CEO talks autoimmune pivot, upcoming lupus readout and his 'thriller or killer' approach

Cullinan CEO talks autoimmune pivot, upcoming lupus rea...

Feb 9, 2025  0

Unlocking Genomic Data: How NashBio is Advancing Innovation in Life Sciences

Unlocking Genomic Data: How NashBio is Advancing Innova...

Apr 7, 2025  0

Solid Bio's stock soars as early DMD gene therapy data beat expectations

Solid Bio's stock soars as early DMD gene therapy data ...

Feb 18, 2025  0